What is the Projected CAGR value of the Neuroendocrine Cancer Market ?
Neuroendocrine Cancer Market is expected to grow at a CAGR of 10.6% during the forecast period (2024-2031)
Who are the key players in Neuroendocrine Cancer Market ?
Major players are Novartis AG, Pfizer Inc., Ipsen, Tarveda Therapeutics, Progenics Pharmaceuticals, Inc., Hutchison Medipharma Limited, Dauntless Pharmaceuticals Inc., Exelixis, Inc., Advanced Accelerator Applications and Argos Therapeutics Inc.